Cargando…

Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America

SARS-CoV-2 is a new member of the genus Betacoronavirus, responsible for the COVID-19 pandemic. The virus crossed the species barrier and established in the human population taking advantage of the spike protein high affinity for the ACE receptor to infect the lower respiratory tract. The Nucleocaps...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franco-Muñoz, Carlos, Álvarez-Díaz, Diego A., Laiton-Donato, Katherine, Wiesner, Magdalena, Escandón, Patricia, Usme-Ciro, José A., Franco-Sierra, Nicolás D., Flórez-Sánchez, Astrid C., Gómez-Rangel, Sergio, Rodríguez-Calderon, Luz D., Barbosa-Ramirez, Juliana, Ospitia-Baez, Erika, Walteros, Diana M., Ospina-Martinez, Martha L., Mercado-Reyes, Marcela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497549/ https://www.ncbi.nlm.nih.gov/pubmed/32950697 http://dx.doi.org/10.1016/j.meegid.2020.104557

Ejemplares similares

Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 detection in the context of genetic variability of the virus in Colombia
por: Álvarez-Díaz, Diego A., et al.
Publicado: (2020)

Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K
por: Laiton-Donato, Katherine, et al.
Publicado: (2021)

Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia
por: Laiton-Donato, Katherine, et al.
Publicado: (2020)

Molecular characterization of dengue virus reveals regional diversification of serotype 2 in Colombia
por: Laiton-Donato, Katherine, et al.
Publicado: (2019)

Secuenciación del SARS-CoV-2: la iniciativa tecnológica para fortalecer los sistemas de alerta temprana ante emergencias de salud pública en Latinoamérica y el Caribe
por: Álvarez-Díaz, Diego A., et al.
Publicado: (2020)

Clinical outcomes associated with Mu variant infection during the third epidemic peak of COVID-19 in Colombia
por: Álvarez-Díaz, Diego A., et al.
Publicado: (2022)

Monkeypox virus genome sequence from an imported human case in Colombia
por: Laiton-Donato, Katherine, et al.
Publicado: (2022)

Aislamiento y caracterización de una cepa temprana de SARS-CoV-2 durante la epidemia de 2020 en Medellín, Colombia
por: Díaz, Francisco J., et al.
Publicado: (2020)

Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
por: Laiton-Donato, Katherine, et al.
Publicado: (2021)

Modelos geoespaciales para control de brotes de SARS-CoV-2 en Cartagena y Barranquilla, Colombia, 2020
por: Zapata Bedoya, Silvana, et al.
Publicado: (2022)

Efficient Method for Molecular Characterization of the 5′ and 3′ Ends of the Dengue Virus Genome
por: Rosales-Munar, Alicia, et al.
Publicado: (2020)

The relevance of dengue virus genotypes surveillance at country level before vaccine approval
por: Usme-Ciro, José A, et al.
Publicado: (2014)

Descriptive analysis of surveillance data for Zika virus disease and Zika virus-associated neurological complications in Colombia, 2015–2017
por: Charniga, Kelly, et al.
Publicado: (2021)

Estimating Zika virus attack rates and risk of Zika virus-associated neurological complications in Colombian capital cities with a Bayesian model
por: Charniga, Kelly, et al.
Publicado: (2022)

Molecular characterization of mosquitoes (Diptera: Culicidae) from the Colombian rainforest
por: Muñoz-Gamba, Andrew S., et al.
Publicado: (2021)

Antibody detection of SARS-CoV spike and nucleocapsid protein
por: Chang, Mau-Sun, et al.
Publicado: (2004)

Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen
por: Dobaño, Carlota, et al.
Publicado: (2022)

SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama
por: Díaz, Yamilka, et al.
Publicado: (2021)

Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays
por: Rikhtegaran Tehrani, Zahra, et al.
Publicado: (2020)

Identification of Conserved Epitopes in SARS-CoV-2 Spike and Nucleocapsid Protein
por: Forcelloni, Sergio, et al.
Publicado: (2021)

Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays
por: Tehrani, Zahra Rikhtegaran, et al.
Publicado: (2020)

Computational studies of the dynamics of SARS-CoV-2 spike, membrane, and nucleocapsid proteins
por: Dutta, Mandira, et al.
Publicado: (2022)

Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese
por: Midorikawa, Rie, et al.
Publicado: (2022)

Assessment of immunoglobin G (spike and nucleocapsid protein) response to COVID-19 vaccination in Palestine
por: Asmar, Imad, et al.
Publicado: (2023)

Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineage
por: Álvarez-Díaz, Diego A., et al.
Publicado: (2022)

Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results
por: Perkmann, Thomas, et al.
Publicado: (2021)

Detection and Molecular Characterization of Zoonotic Poxviruses Circulating in the Amazon Region of Colombia, 2014
por: Usme-Ciro, Jose A., et al.
Publicado: (2017)

Human post‐infection serological response to the spike and nucleocapsid proteins of SARS‐CoV‐2
por: Xiao, Cheng, et al.
Publicado: (2020)

Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity
por: Lee, Eunok, et al.
Publicado: (2021)

Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2
por: Dangi, Tanushree, et al.
Publicado: (2021)

Nucleocapsid and Spike Proteins of SARS-CoV-2 Drive Neutrophil Extracellular Trap Formation
por: Youn, Young-Jin, et al.
Publicado: (2021)

Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms
por: Varnai, Reka, et al.
Publicado: (2022)

Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins
por: O’Donnell, Kyle L., et al.
Publicado: (2022)

Susceptibility of SARS COV-2 nucleocapsid and spike proteins to reactive oxygen species and role in inflammation
por: Pavlova, Elitsa, et al.
Publicado: (2023)

Antibody Response to the SARS-CoV-2 Spike and Nucleocapsid Proteins in Patients with Different COVID-19 Clinical Profiles
por: Soares, Sinei Ramos, et al.
Publicado: (2023)

Severe acute respiratory syndrome coronavirus nucleocapsid protein confers ability to efficiently produce virus-like particles when substituted for the human immunodeficiency virus nucleocapsid domain
por: Wang, Shui-Mei, et al.
Publicado: (2008)

Genotyping of dengue virus from infected tissue samples embedded in paraffin
por: Rivera, Jorge Alonso, et al.
Publicado: (2023)

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
por: Brochot, Etienne, et al.
Publicado: (2020)

Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2
por: Dawood, Reham M., et al.
Publicado: (2021)

Comparative research on nucleocapsid and spike glycoprotein as the rapid immunodetection targets of COVID-19 and establishment of immunoassay strips
por: Liu, Dan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_38noafuaf4bl68hn297nn7plol